Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.

Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.

AMCP mourns the passing of managed care pharmacy icon Judith Cahill. A former CEO of AMCP, Judy led the organization for more than 15 years, growing its membership from 600 to more than 6,000 managed care professionals.

On August 12, the House of Representatives voted to approve the Senate-passed Inflation Reduction Act, containing significant health policy reforms.

On Wednesday, June 8, the House of Representatives voted to approve the Pre-approval Information Exchange Act as part of the Food & Drug Amendments of 2022 to reauthorize the FDA User Fee Agreements.

AMCP is pleased to be recognized by the Office of Disease Prevention and Health Promotion within the U.S. Department of Health and Human Services as a Healthy People 2030 Champion.

Last week, nearly 40 experts and key stakeholders in the managed care setting convened for AMCP’s Partnership Forum: High-Investment Medications.